MYP_063920
Basic Information
SC33EK
Antimicrobial
Antiviral
Antiviral Anti-HIV Anti-HIV-1
Antiviral Antiviral mechanism Viral fusion inhibition
Standard
33 amino acids
C190H303N47O62
Standard
Sequence
WEEWDKKIEEYTKKIEELIKKSEEQQKKNEKEL
Physicochemical Analysis
4237.72 Da
5.08
-2.22
-2.46
-0.0673
-2.05
0.69
-0.50
75.93
59.09
0.0909
12490.00
12490.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1860.54
-12.40
62.0
60.0
159.0
299.0
5.0
35.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0222531 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 HXB2 | TZM-bl cells
0.0007±0.0004 μM
IC50
Mammalian: 2.8 h; Yeast: 3 min; E. coli: 2 min
RECORD: Rec_0359206 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Fusion-inhibitory peptide
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
Acetylation
Amidation
Bio-Activity Profile
Antiviral Anti-HIV-1 Fusion inhibition
HIV-1 NL4-3 | TZM-bl cells
0.0011±0.0001 μM
IC50
Mammalian: 2.8 h; Yeast: 3 min; E. coli: 2 min
Showing 2 records on this page · Page 2 of 2